Sdi Limited
SDI.ASXHealth Care
Manufacture and distribution of amalgam and composite restorative materials, other dental materials, and product research and development.
Latest Earnings
Appendix 4D Dcember 2025
27 February 2026
SDI Limited's H1 FY26 results show modest revenue growth of 2.7% to $52.9M, driven by strong Australian and Middle Eastern markets, but normalised NPAT declined 2.0% to $3.75M after adjusting for a $0.5M doubtful debt provision. Gross margins expanded 210 bps to 65.6% on operational efficiencies and favourable FX, though Amalgam sales collapsed 23.1% due to EU regulatory bans and market decline, partially offset by Aesthetics growth. Management guidance remains cautious with major capital investments planned ($26M facility expansion commencing April 2026) and a potential acquisition in advanced discussions. Key points: Gross margin expanded significantly by 210 bps to 65.6% driven by operational efficiencies, product mix shift towards higher-margin Aesthetics, and favourable currency movements; Aesthetics product category shows strong growth of 4.5% in local currency across all regions; 'Stela' Amalgam replacement product positioned for wider aesthetic market penetration; Australian market momentum strong, up 11.9% in local currency with Middle Eastern direct exports driving growth of 10.2% regionally
Recent Announcements
Appendix 4D Dcember 2025
SDI Limited's H1 FY26 results show modest revenue growth of 2.7% to $52.9M, driven by strong Australian and Middle Eastern markets, but normalised NPAT declined 2.0% to $3.75M after adjusting for a $0.5M doubtful debt provision. Gross margins expanded 210 bps to 65.6% on operational efficiencies and favourable FX, though Amalgam sales collapsed 23.1% due to EU regulatory bans and market decline, partially offset by Aesthetics growth. Management guidance remains cautious with major capital investments planned ($26M facility expansion commencing April 2026) and a potential acquisition in advanced discussions. Key points: Gross margin expanded significantly by 210 bps to 65.6% driven by operational efficiencies, product mix shift towards higher-margin Aesthetics, and favourable currency movements; Aesthetics product category shows strong growth of 4.5% in local currency across all regions; 'Stela' Amalgam replacement product positioned for wider aesthetic market penetration; Australian market momentum strong, up 11.9% in local currency with Middle Eastern direct exports driving growth of 10.2% regionally
Get real-time alerts for SDI
Receive AI-powered earnings summaries and instant notifications when Sdi Limited releases results.
Register Free